Dr. Zilch has acquired a broad overview of various technology-oriented companies in the biotechnology sector during his activities as Business Development manager with the Fraunhofer IZI and Siemens Medical Solutions. His tenure as Senior Consultant and Senior Financial Analyst with CE Capital, ICE Securities as well as ICE Partners, where he was actively involved respectively as an investment banker and VC representative, has given him experience in start-up financing and strategic advising for active portfolios, in particular in the biotechnology, pharma- and medical devices sectors. Additionally he has practical know-how in creation and financing of spin-offs as an initiator of the IT-firm Generation Internex Ltd. in the year 1999 and the consulting firm Innovalis in 2002. In the context of his activity with Siemens Medical Solutions Dr. Zilch was responsible for the evaluation of new diagnostic platform technologies and the coordination of three extensive diagnostics projects. Dr. Zilch is involved in more than 20 patent applications in the IVD field. He completed his training in biochemistry and molecular biology at the Free University of Berlin, at the University College London Medical School and the University of Oxford. Parallel to his biochemistry study and his DAAD-funded postgraduate work at the Tumor Immunology Unit of the Imperial Cancer Research Fund he studied Political Economics at the Free University of Berlin and Management Economics at the correspondence University of Hagen.